SHANGHAI, Aug. 5, 2024 /PRNewswire/ -- Recently, CorrectSequence Therapeutics Co., Ltd. (Correctseq) announced a significant milestone in their base editing therapy CS-101 for transfusion ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
Sept. 16, 2024 /PRNewswire/ -- Today, Prime Therapeutics LLC (Prime) unveils a new corporate vision and brand identity that signifies its bold transformation and commitment to reimagining pharmacy ...
(RTTNews) - Vivos Therapeutics, Inc. (VVOS), a medical device and technology company, announced on Thursday that it has inked a deal with institutional investors to sell 1.363 million shares at $3 ...
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study; Topline Results Expected in October 2024 18.09.2024 / 07:00 CET/CEST Relief Therapeutics Completes Clinical Phase ...
HUNTSVILLE, AL / ACCESSWIRE / August 14, 2024 / Kalm Therapeutics is pleased to announce the $700,000 oversubscribed closing of its seed round to bring the first prescription patch treatment to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback